02/05/2015 - 1:16pm

The Venezeulan government has continued its crackdown on retail in the country for allegedly hoarding products.

02/05/2015 - 11:43am

Generic drug prices are going up. Spurred by market opportunities, short-term market exclusivity for some newly launched single-source generics and rising costs for manufacturing, quality control and raw materials, me-too drug manufacturers have escalated a series of price hikes, some of them significant.

02/05/2015 - 11:42am

In this issue, DSN looks at another three hot spot issues identified by PwC’s HRI that will help define how health care is provided in 2015.

02/05/2015 - 11:16am

HDMA recognized four members of Congress with the Association’s Rx Safety and Healthcare Leadership Award.

02/03/2015 - 3:25pm

Zogenix last week announced that the Food and Drug Administration approved a new formulation of the company's Zohydro ER (hydrocodone bitartrate) extended-release capsules, CII.

02/03/2015 - 3:06pm

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. on Monday announced that the Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets. 

 

02/03/2015 - 12:54pm

New York Attorney General Eric Schneiderman on Monday called on four major retailers to stop selling store-brand herbal supplement products in New York that could not be verified to contain the labeled substance by using what the industry describes as a questionable testing method — DNA barcoding.

02/02/2015 - 5:48pm

A proposal in the Budget of the U.S. government, fiscal year 2016 calls for an increase in retail pharmacy prescription drug co-pays.

02/02/2015 - 10:43am

The Food and Drug Administration announced that it has expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults, making it the first FDA-approved medicine to treat this condition.